Scientific Program

  • To see the program overview of the previous Autoimmunity Congress in 2016, please click here.
  • To review the full program book of the previous Autoimmunity Congress in 2016, please click here.

Academy of Autoimmunity full program, Please click here

Tentative Lecture Topics
TopicSpeaker \ Title
Antiphospholipid (APS)
Roger Levy (Brazil): New treatments and challenges in APS

Tatsuya Atsumi (Japan): Pathogenic role of antiphospholipid antibodies

Luis J. Jara (Mexico): Non-criteria or Seronegative Obstetric Antiphospholipid Syndrome
Pier Luigi Meroni (Italy): New ismight in APS pathogenesis

Maria J Cuadrado (UK): Negativitation of antiphospholipid antibodies in patients with APS: patients phfenotype, prothombotic status and therapeutic decisions
New AutoantibodiesLuis E. Andrade (Brazil): Anti-DFS70 antibodies: the puzzle of high titer and persistent autoantibodies in healthy individuals

Edward Chan (USA): Advances in the immunobiology of rod/ring autoantigenic structures
Infection and AutoimmunityDimitrios Bogdanos (Greece); A close interplay between infectome and regulatome in autoimmunity: emerging data
Prediction Of AutoimmunityAthanasios Tzioufas (Greece): Advances in Predictive markers for lymphoma development in Sjögren's syndrome
IVIGAdrian Zuercher (Switzerland),Fabian Käsermann (Switzerland)  : Novel mechanism by which IVIG can immunomodulate autoimmunity
ANCA and VasculitisJan Willem Cohen Tervaert (Netherlands): How to avoid relapses in ANCA-associated vasculitis
B and T regulatory cellsKazuhiko Yamamoto (Japan): Regulatory T cells in autoimmune diseases
Dimitrios Bogdanos (Greece): B regulatory cells as makers of autoimmunity and markers of response to treatment: real data from the clinic
Complement and Immune complexesBetty Diamond (USA): C1q and Immune homeostasis
Pregnancy and new born in AutoimmunityRoger Levy (Brazil): Pregnancy and SLE\ APS
Angela Tincani (Italy): Counselling patients with rheumatic diseases in fertile age, The use of antirheumatic drugs before and during pregnancy
ASIA SyndromeJan Willem Cohen Tervaert (Netherlands): ASIA due to implanted foreign bodies: what-a-MESH  
Marzena Olesinska (Poland) : „Sine" syndromes in rheumatology.
Novel avenues in systemic sclerosisMaurizio Cutolo (Italy):  Very new pathways in systemic sclerosis: from the immune system reaction up to the complex autoimmune disease
Claudio Lunardi (Italy) :  Pulmonary arterial hypertension in systemic sclerosis: a single centre study.
Luc Mouthon (France) : Implication of B lymphocytes in the pathogenesis of systemic sclerosis
Autoimmunity in the brainBetty Diamond (USA): Brain-reactive antibodies
Yoav Chapman (Israel) : Neurodegenerative and autoimmunity from animal models to the future of Alzheimer disease
Angela Vincent (UK): Novel CNS autoantibodies

David Naor (Israel)Therapeutic activities  of human 5-mer peptide, targeting  polymeric proteins in autoimmune, inflammatory and neurodegenerative  maladies.
IL-17 and other cytokinesPierre Miossec (France): Update on IL-17 function and targeting
Laurent Arnaud (France): Targeting interferons and their pathways in Systemic Lupus Erythematosus

Smoke, smoking, nicotine and autoimmune diseases

Carlo Perricone (Italy): Smoke in autoimmunity: the smoking gun

Wattad Abdullah:  Nicotine and autoimmunity. Smokeless Cigarette and autoimmunity. 
Novel therapies in autoimmune diseasesYaakov Naparstek (Israel): HSP60 - a novel target for protective antibodies in autoimmune diseases

David Naor (Israel): 5-mer peptide, targeting amyloid proteins,  displays a therapeutic   "Janus faced" activity  in autoimmune, inflammatory and neurodegenerative  maladies.

Maria J Cuadrado (UK): Biosimilars: The sharing gain model from UK
Corticsteroid : Do we need them?Maurizio Cutolo (Italy): Glucocorticoid replacement therapy in autoimmune connective tissue diseases
Yaakov Naparstek (Israel): A liposomal based steroidal nano drug: A novel approach for the treatment of autoimmune diseases
Genetics in autoimmunityCarlo Perricone (Italy): Genetic of arthritis: the weight of environment
Kazuhiko Yamamoto (Japan): Genetics and epigenetics of autoimmune diseases
Environment and AutoimmunityEric Gershwin (USA): The Environment—the Serendipity Component of Autoimmunity

Autoimmune Blood Diseases

Douglas Cines (USA): Role of neutrophils defensin as an intermediary between innate immunity/inflammation with thrombosis and atherosclerosis
Eiji Matsuura (Japan): Autoimmunity and angiogenesis 
Roberto Gerli (Italy): New insight in the role of platelets in arthritis
SLE (LUPUS)Chaim Putterman (USA):  Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis
Tadej Avcin (Slovenia): STAT signalling as a marker of SLE disease severity and implications of STAT inhibition for clinical therapy
Ian Bruce (UK): Long-term Damage in SLE: can we do better?
Dilemmas In Diagnosis In Autoimmune DiseasesEdward Chan (USA): The international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns (ICAP) initiative - Establishment of an Interpretative Clinical Description for Each Pattern.
Nicola Bizzaro (Italy): Is immunofluorescence still the reference method for ANA?
Multiplex Diagnostic Techniques And ChipsZoltán Szekanecz (Hungary): Autoimmune and angiogenic biomarkers of autoimmune atherosclerosis
Guy Serre (Israel): ACPA, RF, and macrophages: the main players in Rheumatoid Arthritis
B CellsVeerle Somers (Belgium): Role of B cells and antibodies in MS
Pierre Youinou (France): Toll-like receptors drive the B cell-mediated autoimmune process


T Cells

George Tsokos (USA): CaMK4, a serine threonine kinase, links T cells to podocytes: cell targeted treatment in lupus.

Luc Mouthon (France): Autoimmunity in idiopathic CD4 lymphocytopenia
DiabetesTomer Yaron (USA): Interferon alpha as the master  trigger of  type 1 diabetes
Matthias  Von Herrath (USA): Autoimmune reactivity in human type 1 and 2 diabetes
Luis J. Jara (Mexico): Neuroendocrine-immune system and Autoimmune Rheumatic Diseases
Immune Deficiency And AutoimmunityLuis E.Andrade (Brazil): The interface between autoimmunity and immunodeficiency
Tadej Avcin (Slovenia): Mechanisms of autoimmunity in primary immunodeficiencies and implications for targeted therapeutics
Cancer And AutoimmunityCancer immunotherapy and its immunologic complications (academy of autoimmunity)

Keep Me Updated